Medicine
Divalproex 125 mg delayed-release capsule
Divalproex 125 mg delayed-release capsule is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°-25°C (68°-77°F),.
Key facts
- Active ingredient (INN)
- Divalproex
- Brand
- Sold under the generic name
- Strength
- 125 mg
- Dosage form
- Delayed-release capsule
- Route
- Oral
- Packs
- 100 blister pack, 100 capsules, 1000 capsules and 12 more
- Manufacturers
- Alembic PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaNorthStar RxCardinal HealthMajor Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°-25°C (68°-77°F),.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AG01 Valproic acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 January 2009
- Identifiers
- RxCUI 1099596DailyMed set ID f911748c-fb3a-fe1a-ab2a-4b40455e05ef, 589ae3a6-8b2e-d931-d36b-1937287ab5c0, f34c4504-5409-406e-995b-138e5f700242 +3NDC 55111-532, 72603-260, 46708-821 +3Application ANDA078979, ANDA218793
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack | 46708-821-10 | Alembic PharmaceuticalsIndia | 23 December 2024 |
| 100 capsule, delayed release in 1 bottle | 46708-821-31 | Alembic PharmaceuticalsIndia | 23 December 2024 |
| 1000 capsule, delayed release in 1 bottle | 46708-821-91 | Alembic PharmaceuticalsIndia | 23 December 2024 |
| 100 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack | 62332-821-10 | Alembic PharmaceuticalsIndia | 23 December 2024 |
| 100 capsule, delayed release in 1 bottle | 62332-821-31 | Alembic PharmaceuticalsIndia | 23 December 2024 |
| 500 capsule, delayed release in 1 bottle | 62332-821-71 | Alembic PharmaceuticalsIndia | 21 March 2025 |
| 1000 capsule, delayed release in 1 bottle | 62332-821-91 | Alembic PharmaceuticalsIndia | 23 December 2024 |
| 100 capsule, delayed release in 1 bottle | 55111-532-01 | Dr. Reddy's LaboratoriesIndia | 23 January 2009 |
| 500 capsule, delayed release in 1 bottle | 55111-532-05 | Dr. Reddy's LaboratoriesIndia | 23 January 2009 |
| 30 capsule, delayed release in 1 bottle | 55111-532-30 | Dr. Reddy's LaboratoriesIndia | 23 January 2009 |
| 10 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack | 55111-532-78 | Dr. Reddy's LaboratoriesIndia | 23 January 2009 |
| 10 blister pack in 1 bag / 1 capsule, delayed release in 1 blister pack | 55154-3552-0 | Cardinal Health | 23 January 2009 |
| 100 blister pack in 1 carton / 1 capsule, delayed release in 1 blister pack | 0904-6615-61 | Major Pharmaceuticals | 23 January 2009 |
| 100 capsule, delayed release in 1 bottle | 72603-260-01 | NorthStar Rx | 1 August 2024 |
| 500 capsule, delayed release in 1 bottle | 72603-260-02 | NorthStar Rx | 1 August 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 March 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Divalproex
Clinical summary
Divalproex is an anti-epileptic agent indicated for treatment of manic episodes associated with bipolar disorder, among other approved uses. It is available as delayed-release tablets, extended-release tablets and capsules for oral use. MedsAcross supplies Divalproex for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DivalproexFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Depakote prescribing information (AbbVie) · U.S. National Library of Medicine, DailyMed
Need Divalproex 125 mg delayed-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.